|
|
Legal status
Patent not validated
| (51) | INT.CL. | A01N 33/26 | |
| A61K 31/655 | |||
| A61P 1/06 | |||
| A61P 1/00 |
| (11) | Number of the document | 2563117 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11775497.8 |
| Date of filing the European patent application | 2011-04-26 | |
| (97) | Date of publication of the European application | 2013-03-06 |
| (45) | Date of publication and mention of the grant of the patent | 2018-02-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/033905 |
| Date | 2011-04-26 |
| (87) | Number | WO 2011/137103 |
| Date | 2011-11-03 |
| (30) | Number | Date | Country code |
| 328151 P | 2010-04-26 | US |
| (72) |
FORBES, William, US
BORTEY, Enoch, US
JOHNSON, Lorin, US
|
| (73) |
Salix Pharmaceuticals, Ltd.,
8510 Colonnade Center Drive, Raleigh, NC 27615,
US
|
| (54) | FORMULATIONS AND USES OF 2-HYDROXY-5-PHENYLAZOBENZOIC ACID DERIVATIVES FOR THE TREATMENT OF MALES |
| FORMULATIONS AND USES OF 2-HYDROXY-5-PHENYLAZOBENZOIC ACID DERIVATIVES FOR THE TREATMENT OF MALES |